ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Pourfathollah AA

Faculty of Medical Sciences, c and Blood Transfusion Research Centre, High Institute for Research Centre and Education in Transfusion Medicine, Tehran, Iran

Biography

Dr. Pourfathollah AA is currently working as a faculty in medical sciences department at Tarbiat Modares University and also as a researchers in Blood Transfusion Research Centre, High Institute for Research Centre and Education in Transfusion Medicine, Tehran, Iran. His areas of research field includes such as medical sciences, Blood Transfusion, Transfusion Medicine, blood diseases and disorders.
Publications

A Fatal Case of Cefazolin-Induced Immune Hemolytic Anemia in Iran

Introduction: Drug-induced immune hemolytic anemia (DIIHA) is known as an unpredictable and in some cases serious complication occurring upon pharmacotherapy. Cefazolin, as a first generation cephalosporin used against gram-negative bacteria, has rarely been reported to cause hemolytic anemia. Here, we report the first fatal case of hemolytic anemi... Read More»

Moghaddam M, Razzaghi F, Sheibani H and Pourfathollah AA

Case Report: J Clin Exp Pathol 2016, 6: 296

DOI: 10.4172/2161-0681.1000296

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top